 | • レポートコード：B-GIR09D4349 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、子宮肉腫治療の世界市場について調べ、まとめました。種類別セグメントは、手術、放射線療法、ホルモン療法等、用途別セグメントは、病院、診療所、その他等に区分しました。子宮肉腫治療の世界市場概観、企業動向、企業別子宮肉腫治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・子宮肉腫治療の市場概観 ・子宮肉腫治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・子宮肉腫治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・子宮肉腫治療の世界市場規模 ・子宮肉腫治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・子宮肉腫治療のアメリカ市場規模推移 ・子宮肉腫治療のカナダ市場規模推移 ・子宮肉腫治療のメキシコ市場規模推移 ・子宮肉腫治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・子宮肉腫治療のドイツ市場規模推移 ・子宮肉腫治療のイギリス市場規模推移 ・子宮肉腫治療のロシア市場規模推移 ・子宮肉腫治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・子宮肉腫治療の日本市場規模推移 ・子宮肉腫治療の中国市場規模推移 ・子宮肉腫治療の韓国市場規模推移 ・子宮肉腫治療のインド市場規模推移 ・子宮肉腫治療の東南アジア市場規模推移 ・子宮肉腫治療の南米市場分析（ブラジル、アルゼンチン等） ・子宮肉腫治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・子宮肉腫治療の種類別分析/販売量、売上、市場シェア（手術、放射線療法、ホルモン療法） ・子宮肉腫治療の用途別分析/市場規模（病院、診療所、その他） ・子宮肉腫治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・子宮肉腫治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Sarcomas are the tumours of the mesenchymal tissues like bone, muscle, connective tissue, cartilage and fat. Uterine sarcoma is a rare type of cancer which starts in the muscle and supporting tissues of the uterus. Exposure to the X-rays increases the risk for uterine sarcoma.
Scope of the Report:
The global Uterine Sarcoma Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Uterine Sarcoma Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Uterine Sarcoma Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Uterine Sarcoma Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Johnson & Johnson
General Electric
Koninklijke Philips
Siemens Healthcare
Intas Pharmaceuticals
Sun Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Surgery
Radiation Therapy
Hormone Therapy
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
Table of Contents
1 Uterine Sarcoma Treatment Market Overview
1.1 Product Overview and Scope of Uterine Sarcoma Treatment
1.2 Classification of Uterine Sarcoma Treatment by Types
1.2.1 Global Uterine Sarcoma Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Uterine Sarcoma Treatment Revenue Market Share by Types in 2018
1.2.3 Surgery
1.2.4 Radiation Therapy
1.2.5 Hormone Therapy
1.3 Global Uterine Sarcoma Treatment Market by Application
1.3.1 Global Uterine Sarcoma Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Uterine Sarcoma Treatment Market by Regions
1.4.1 Global Uterine Sarcoma Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Uterine Sarcoma Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Uterine Sarcoma Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Uterine Sarcoma Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Uterine Sarcoma Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Uterine Sarcoma Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Uterine Sarcoma Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Uterine Sarcoma Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Uterine Sarcoma Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 General Electric
2.3.1 Business Overview
2.3.2 Uterine Sarcoma Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 General Electric Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Koninklijke Philips
2.4.1 Business Overview
2.4.2 Uterine Sarcoma Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Koninklijke Philips Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Siemens Healthcare
2.5.1 Business Overview
2.5.2 Uterine Sarcoma Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Siemens Healthcare Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Intas Pharmaceuticals
2.6.1 Business Overview
2.6.2 Uterine Sarcoma Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Intas Pharmaceuticals Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sun Pharmaceutical
2.7.1 Business Overview
2.7.2 Uterine Sarcoma Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sun Pharmaceutical Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Uterine Sarcoma Treatment Market Competition, by Players
3.1 Global Uterine Sarcoma Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Uterine Sarcoma Treatment Players Market Share
3.2.2 Top 10 Uterine Sarcoma Treatment Players Market Share
3.3 Market Competition Trend
4 Global Uterine Sarcoma Treatment Market Size by Regions
4.1 Global Uterine Sarcoma Treatment Revenue and Market Share by Regions
4.2 North America Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
5 North America Uterine Sarcoma Treatment Revenue by Countries
5.1 North America Uterine Sarcoma Treatment Revenue by Countries (2014-2019)
5.2 USA Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
6 Europe Uterine Sarcoma Treatment Revenue by Countries
6.1 Europe Uterine Sarcoma Treatment Revenue by Countries (2014-2019)
6.2 Germany Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
6.4 France Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Uterine Sarcoma Treatment Revenue by Countries
7.1 Asia-Pacific Uterine Sarcoma Treatment Revenue by Countries (2014-2019)
7.2 China Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
7.5 India Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
8 South America Uterine Sarcoma Treatment Revenue by Countries
8.1 South America Uterine Sarcoma Treatment Revenue by Countries (2014-2019)
8.2 Brazil Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Uterine Sarcoma Treatment by Countries
9.1 Middle East and Africa Uterine Sarcoma Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
10 Global Uterine Sarcoma Treatment Market Segment by Type
10.1 Global Uterine Sarcoma Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Uterine Sarcoma Treatment Market Forecast by Type (2019-2024)
10.3 Surgery Revenue Growth Rate (2014-2024)
10.4 Radiation Therapy Revenue Growth Rate (2014-2024)
10.5 Hormone Therapy Revenue Growth Rate (2014-2024)
11 Global Uterine Sarcoma Treatment Market Segment by Application
11.1 Global Uterine Sarcoma Treatment Revenue Market Share by Application (2014-2019)
11.2 Uterine Sarcoma Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Uterine Sarcoma Treatment Market Size Forecast (2019-2024)
12.1 Global Uterine Sarcoma Treatment Market Size Forecast (2019-2024)
12.2 Global Uterine Sarcoma Treatment Market Forecast by Regions (2019-2024)
12.3 North America Uterine Sarcoma Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Uterine Sarcoma Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Uterine Sarcoma Treatment Revenue Market Forecast (2019-2024)
12.6 South America Uterine Sarcoma Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Uterine Sarcoma Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Uterine Sarcoma Treatment Picture
Table Product Specifications of Uterine Sarcoma Treatment
Table Global Uterine Sarcoma Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Uterine Sarcoma Treatment Revenue Market Share by Types in 2018
Figure Surgery Picture
Figure Radiation Therapy Picture
Figure Hormone Therapy Picture
Table Global Uterine Sarcoma Treatment Revenue (Million USD) by Application (2014-2024)
Figure Uterine Sarcoma Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Uterine Sarcoma Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Uterine Sarcoma Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Uterine Sarcoma Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Uterine Sarcoma Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Uterine Sarcoma Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Uterine Sarcoma Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Uterine Sarcoma Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Uterine Sarcoma Treatment Type and Applications
Table Pfizer Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Uterine Sarcoma Treatment Type and Applications
Table Johnson & Johnson Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table General Electric Basic Information, Manufacturing Base and Competitors
Table General Electric Uterine Sarcoma Treatment Type and Applications
Table General Electric Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Koninklijke Philips Basic Information, Manufacturing Base and Competitors
Table Koninklijke Philips Uterine Sarcoma Treatment Type and Applications
Table Koninklijke Philips Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table Siemens Healthcare Uterine Sarcoma Treatment Type and Applications
Table Siemens Healthcare Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Intas Pharmaceuticals Uterine Sarcoma Treatment Type and Applications
Table Intas Pharmaceuticals Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Uterine Sarcoma Treatment Type and Applications
Table Sun Pharmaceutical Uterine Sarcoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Uterine Sarcoma Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Uterine Sarcoma Treatment Revenue Share by Players (2014-2019)
Figure Global Uterine Sarcoma Treatment Revenue Share by Players in 2017
Figure Global Uterine Sarcoma Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Uterine Sarcoma Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Uterine Sarcoma Treatment Revenue Market Share in 2018
Figure Global Uterine Sarcoma Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Uterine Sarcoma Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Uterine Sarcoma Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Uterine Sarcoma Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Uterine Sarcoma Treatment Revenue Market Share by Regions in 2018
Figure North America Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure South America Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Table North America Uterine Sarcoma Treatment Revenue by Countries (2014-2019)
Table North America Uterine Sarcoma Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Uterine Sarcoma Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Uterine Sarcoma Treatment Revenue Market Share by Countries in 2018
Figure USA Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Table Europe Uterine Sarcoma Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Uterine Sarcoma Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Uterine Sarcoma Treatment Revenue Market Share by Countries in 2018
Figure Germany Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure UK Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure France Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Uterine Sarcoma Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Uterine Sarcoma Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Uterine Sarcoma Treatment Revenue Market Share by Countries in 2018
Figure China Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure India Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Table South America Uterine Sarcoma Treatment Revenue by Countries (2014-2019)
Table South America Uterine Sarcoma Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Uterine Sarcoma Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Uterine Sarcoma Treatment Revenue Market Share by Countries in 2018
Figure Brazil Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Uterine Sarcoma Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Uterine Sarcoma Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Uterine Sarcoma Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Uterine Sarcoma Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Uterine Sarcoma Treatment Revenue and Growth Rate (2014-2019)
Table Global Uterine Sarcoma Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Uterine Sarcoma Treatment Revenue Share by Type (2014-2019)
Figure Global Uterine Sarcoma Treatment Revenue Share by Type (2014-2019)
Figure Global Uterine Sarcoma Treatment Revenue Share by Type in 2019
Table Global Uterine Sarcoma Treatment Revenue Forecast by Type (2019-2024)
Figure Global Uterine Sarcoma Treatment Market Share Forecast by Type (2019-2024)
Figure Global Surgery Revenue Growth Rate (2014-2019)
Figure Global Radiation Therapy Revenue Growth Rate (2014-2019)
Figure Global Hormone Therapy Revenue Growth Rate (2014-2019)
Table Global Uterine Sarcoma Treatment Revenue by Application (2014-2019)
Table Global Uterine Sarcoma Treatment Revenue Share by Application (2014-2019)
Figure Global Uterine Sarcoma Treatment Revenue Share by Application (2014-2019)
Figure Global Uterine Sarcoma Treatment Revenue Share by Application in 2019
Table Global Uterine Sarcoma Treatment Revenue Forecast by Application (2019-2024)
Figure Global Uterine Sarcoma Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Uterine Sarcoma Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Uterine Sarcoma Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Uterine Sarcoma Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Uterine Sarcoma Treatment Revenue Market Forecast (2019-2024)
Figure Europe Uterine Sarcoma Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Uterine Sarcoma Treatment Revenue Market Forecast (2019-2024)
Figure South America Uterine Sarcoma Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Uterine Sarcoma Treatment Revenue Market Forecast (2019-2024)
子宮生検鉗子市場：世界及び中国市場分析・予測（～2024年） Uterine Biopsy Forceps Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Uterine Biopsy Forceps industry with a focus on the Chinese market. The report provides key statistics on the market status of the Uterine Biopsy Forceps m…- 世界の腱炎治療市場予測（～2024年） Tendinitis is irritation or inflammation of a tendon, a thick cord that attaches muscle to bone. Tendinitis is also called tendonitis. Tendinitis mainly caused due to sudden injury or activities that put stress on the tendons. Scope of the Report: The global Tendinitis Treatment market is valued at …
- 世界のレフサム病治療市場予測（～2024年） Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. Scop…
- 世界の消失性骨疾患治療市場予測（～2024年） Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteo…
- 世界の無眼球症および小眼球症治療市場予測（～2024年） Anophthalmia and microphthalmia mean the absence of an eye and the presence of a small eye within the orbit. Anophthalmia and microphthalmia are interchangeable. Whereas, microphthalmia is a disorder in which one or both eyes are abnormally small, while anophthalmia is the absence of one or both eye…